Close

Financial results for the year 2009 of Zimmer Holdings, Inc. reports a decrease of 5.5%

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Rise in Healthcare Grows Medical Device Technologies Market

The global medical device technologies market, which is valued...

AI-Powered IoMT to Transform Healthcare, says Study

A new study goes on to suggest that artificial...

Global Bio-Implants Market to Witness a CAGR of 7% Till 2034

According to Statifacts, the global bio-implants market size is...

The financial results reported by Zimmer Holdings, Inc. for the quarter ended June 30, 2009. shows the second quarter net sales of $1.02 billion, a decrease of 5.5% reported and 0.6% constant currency from the second quarter of 2008. Diluted earnings per share for the quarter were $0.98 reported and $1.00 adjusted, a decrease of 2.9% adjusted from the prior year period.

* Net Sales of $1.02 billion represents a decrease of 5.5% reported (0.6% constant currency)

* Diluted EPS for the second quarter were $0.98 reported, a decrease of 1.0% from the prior year period, and $1.00 adjusted, a decrease of 2.9% from the prior year period.

* Reaffirms full-year sales and adjusted EPS guidance

David Dvorak, Zimmer President and CEO said, Our second quarter results provide further evidence that we are successfully stabilizing our business and making progress toward restoring positive momentum. We achieved sequential improvement in revenue on a day-rate basis for the quarter in six of our seven product categories, including Knees and Hips.  We are once again reaffirming our 2009 sales and earnings guidance.

Net earnings for the second quarter were $210.1 million on a reported basis and $215.5 million on an adjusted basis, a decrease of 9.0% adjusted from the prior year period.  Operating cash flow for the second quarter was $195.1 million.  Net earnings for the first six months of 2009 were $412.3 million on a reported basis and $425.5 million on an adjusted basis, a decrease of 11.6% adjusted from the prior year period.

During the quarter, the Company utilized $36 million of cash to acquire 0.8 million shares under its $1.25 billion repurchase program.  At the end of the quarter, $797 million of share repurchase authorization remained available under this program, which expires on December 31, 2009.

Contacts

Media

Latest stories

Related stories

Rise in Healthcare Grows Medical Device Technologies Market

The global medical device technologies market, which is valued...

AI-Powered IoMT to Transform Healthcare, says Study

A new study goes on to suggest that artificial...

Global Bio-Implants Market to Witness a CAGR of 7% Till 2034

According to Statifacts, the global bio-implants market size is...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back